GLP-1 Patches: What's Actually in Them and What the FDA and FTC Say

“GLP-1 patches” don’t contain GLP-1. The ones that have been reviewed list blends of plant extracts and nutrients, such as berberine, cinnamon or caffeine, and none has been shown in a clinical trial to cause weight loss^[1,2]. Even if a patch did contain semaglutide or tirzepatide, a molecule that size can’t cross intact skin from an adhesive patch^[4,5]. And no approved GLP-1 medication comes as a patch: every one is an injection or a tablet^[11].

Here’s what these patches list, why they can’t act like a GLP-1 drug, what the FDA and FTC have said, how to spot the ads and what to do if you already bought one. “Natural GLP-1” supplements you swallow, like berberine, fiber and probiotics, are covered in “natural Ozempic” and GLP-1 supplements.

What GLP-1 patches promise

GLP-1 is a gut hormone that helps you feel full, and drugs like Ozempic, Wegovy and Zepbound mimic it, as I explain in what GLP-1 medications are. The patches borrow the name. The claims that regulators have documented include:

• Disease treatment. A microneedle patch sold on eBay was advertised for “Type 2 Diabetes Treatment,” “Weight Loss” and “Cardiovascular Protection,” with a “Global User Survey” scoring it between 97.5% and 98.6%^[2].
• Fat burning. The same listing said the patch contained “fat-burning ingredients (such as caffeine, green tea extract, or other thermogenic compounds)” to “stimulate fat metabolism” and “reduce cellulite”^[2].
• Appetite control. A pack flagged by Colombia’s drug regulator promised 30 “Metabolic Balance Patches” for one month to “Combat Snacking,” with “Steady Release”^[18].

What’s actually in them: plant extracts, not GLP-1

Three independent looks at these products found no GLP-1 and no drug that mimics it:

The US review flagged more problems. None of the products posted a certificate of analysis, the lab document that shows what a batch actually contains. Many lacked the FDA disclaimer, and many used deceptive advertising^[1]. That disclaimer, “This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease,” is required by law whenever a supplement makes a structure/function claim^[3].

For a patch to work, OCU points out, its ingredients would have to cross the skin in meaningful amounts and then cause weight loss in rigorous trials. Neither has been shown^[17]. Even swallowed, the evidence for berberine is weak, as I cover in the supplements guide.

Why a GLP-1 can’t get through the skin from a patch

The skin’s outer layer, the stratum corneum, is a very effective barrier. A classic dermatology paper proposed the “500 Dalton rule” in 2000: to be absorbed through the skin, a molecule has to weigh less than about 500 daltons (Da, the unit used for molecular mass). Every drug then used in transdermal patches met that limit^[4]. A 2008 review in Nature Biotechnology put it this way: conventional patches deliver small, fat-soluble, low-dose drugs^[5].

GLP-1 drugs are peptides, chains of amino acids, and they’re far bigger:

One g/mol equals one dalton.

Getting them into the blood is hard even through the gut. Injected under the skin, Wegovy’s semaglutide has an absolute bioavailability of 89%, meaning almost the whole dose reaches the bloodstream. Wegovy tablets carry an absorption enhancer, salcaprozate sodium (SNAC), and still reach an absolute bioavailability of approximately 1% to 2%^[6]. If a tablet built for the job gets 1% to 2% through, I know of no mechanism by which an adhesive patch without needles would do better.

What researchers are working on is microneedle patches: very short needles that pierce the stratum corneum^[5]. A 2025 study notes that getting peptides through the skin with conventional penetration enhancers is “almost impossible.” Its liraglutide microneedle patch reached a relative bioavailability, compared with an injection, of 69.8% in rats and 46.3% in minipigs^[8]. A 2026 review of new GLP-1 delivery methods stresses that these technologies are at an early stage and need more studies of safety and effectiveness^[9].

No approved GLP-1 comes as a patch

I checked the dosage forms of every GLP-1 drug in Drugs@FDA as of October 5, 2026^[11]:

The pills are covered in GLP-1 pills, each drug in the semaglutide and tirzepatide guides, and the brand and generic names in GLP-1 generic and brand names.

The only semaglutide patch I found on ClinicalTrials.gov is in a Phase 1 trial, the first in humans. It compares a microneedle patch with the injection in about 62 adults with overweight or obesity in Arizona. It started on June 15, 2026, with primary completion estimated for February 2027^[10]. A Phase 1 trial measures safety and how much drug reaches the blood, not weight loss; Phase 2 and 3 trials would still have to follow.

What the FDA has said

The microneedle patch letter. On March 31, 2026, the FDA sent a warning letter to the eBay seller of the “SMGT-GLT-1 Nano Microneedle Patch.” Because of its claims to treat diabetes and cause weight loss, the agency called it a drug, and since it isn’t generally recognized as safe and effective and has no approval, an unapproved new drug. The FDA asked for a written response within 15 working days and warned that failing to fix the violations could lead to seizure and injunction^[2]. The letter doesn’t say the patch contained semaglutide; the listing named caffeine and green tea extract.

A patch can’t be a supplement. Under the Dietary Supplement Health and Education Act of 1994 (DSHEA), a dietary supplement is a product intended for ingestion, and the FDA can’t approve supplements before they’re sold^[3]. That’s why the University of Connecticut authors conclude that every patch they found marketed as a “natural GLP-1” supplement is illegal^[1].

The same playbook in drops. In December 2024, the FDA called a seller’s “GLP-1” drops unapproved new drugs, misbranded because the labeling falsely suggested FDA approval. The site claimed users lost “up to 52 pounds in 3 months during clinical trials” and showed an “FDA APPROVED” badge^[12].

For the real drugs, the FDA’s advice is to get a prescription from your doctor and fill it at a state-licensed pharmacy, and not to buy products labeled “for research purposes” or “not for human consumption”^[16]. Why compounded semaglutide isn’t a generic is in generic semaglutide: patents and approvals.

What the FTC has said

The Federal Trade Commission polices advertising, and it has been saying the same thing about patches for almost two decades:

• 2007. A maker of sea kelp weight-loss patches paid $180,000 and was banned from selling weight-loss patches. It had supplied retailers with sample ads and “bogus substantiation materials,” including purported expert endorsements and clinical studies, and claimed the FDA had approved its main ingredient for weight loss^[15].
• 2014. The FTC’s “Gut Check” guide for media lists seven weight-loss claims that “simply can’t be true.” Number seven is causing substantial weight loss by wearing a product or rubbing it into the skin: “Weight loss is an internal metabolic process”^[13].
• 2025. Its consumer guide lists “Lose weight with this patch or cream” among the false promises in weight-loss ads, with the answer “(You can’t.)”^[14].

Outside the US

Regulators in Latin America have gone further and named patches directly. Chile’s Public Health Institute declared “PATCHES GLP-1,” sold online under several brands, illegal to import, use or sell, an alert the consumer agency SERNAC echoed in November 2025^[19]. Colombia’s INVIMA called a “GLP-1 PATCHES” product sold for weight control fraudulent in April 2026^[18]. In February 2026, Mexico’s COFEPRIS warned about unregistered products sold online as “tirzepatide” in drops, patches, vials and syringes; one cartridge labeled tirzepatide held semaglutide and bacterial growth^[20].

How to spot a GLP-1 patch ad

No single sign proves fraud, but each one is a reason to be suspicious:

• “GLP-1,” “Ozempic” or a name that sounds like a drug, like the “SMGT-GLT-1” in the FDA letter^[2]. No approved GLP-1 is a patch^[11].
• Claims to treat diabetes or protect the heart. Those claims are what made the FDA treat a patch as an unapproved drug^[2].
• “FDA approved” badges. The FDA doesn’t approve supplements^[3], and it called a fake “FDA APPROVED” badge misbranding^[12].
• Pounds with a deadline, like “52 pounds in 3 months”^[12].
• Survey scores in the high 90s with no study behind them^[2].
• Fake news stories and fake reviews. The FTC warns about sites that copy real news outlets’ logos, reviews written by the seller and before-and-after photos that are stock or altered images^[14].
• “Free” trials that end in recurring charges and shipments you didn’t want^[14].
• No certificate of analysis and no FDA disclaimer on a product sold as a supplement^[1,3].

If you already bought or used one

Chile’s and Colombia’s regulators tell people to stop using the patches they flagged^[18,19]. Beyond that:

• Watch your skin. OCU notes that these patches can cause irritation, dermatitis or skin allergies, which are harder to sort out when you don’t know what’s in them^[17]. If something looks off, get it checked.
• Tell your prescriber, especially if you have diabetes or take other medications, and bring the package or a photo. A patch is no substitute for a prescribed treatment, and any change to your medication is a conversation with the person who prescribes it. The doctor visit checklist can help you organize your questions.
• Report it. You can report a problem with a supplement to the FDA’s Safety Reporting Portal^[3], and problems with drug products to MedWatch^[16]. False advertising goes to the FTC at ReportFraud.ftc.gov or to your state attorney general^[14].

And if what you’re after is a way to eat almost nothing, or food has become a source of anxiety, please talk to a professional. Eating disorders are treatable.

FAQ

Do GLP-1 patches work for weight loss?

No published trial shows they do. The ones reviewed list plant extracts and nutrients, not GLP-1^[1,2], and the FTC says nothing you wear or apply to your skin will cause you to lose weight^[14].

Do GLP-1 patches contain semaglutide or tirzepatide?

The ones reviewed list ingredients like berberine, cinnamon, glutamine, caffeine or green tea extract^[1,2]. A product sold outside the legal supply chain that claims to contain one of these drugs is unapproved and of unknown quality^[16]. And even if a patch did contain one, a molecule of roughly 4,100 to 4,800 daltons can’t cross the skin from an adhesive patch^[4,6,7].

Is there an Ozempic or Zepbound patch?

No. Ozempic, Wegovy, Mounjaro and Zepbound injections go under the skin, and the only oral GLP-1s are tablets^[11]. A microneedle semaglutide patch is in its first Phase 1 trial in humans, with primary completion estimated for 2027^[10].

Are GLP-1 patches legal in the US?

Not as dietary supplements, which by law have to be swallowed, according to the 2026 review^[1,3]. And when a patch claims to treat diabetes, the FDA treats it as an unapproved new drug^[2].

Can I use a GLP-1 patch while I’m on Ozempic or Zepbound?

That’s a question for your prescriber or pharmacist. The patch won’t add a GLP-1, but it may contain ingredients the label doesn’t list properly^[1], and some, like berberine, interact with medications when taken by mouth.